Biotech · Private company
Revolo Biotherapeutics
Track this companyFree. Adds Revolo Biotherapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- IRL201104Phase 2 · Eosinophilic EsophagitisClinicalTrials.gov · fetched Nov 12, 2026
- IRL201104Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy VolunteersPHASE1 · COMPLETED · started May 26, 2023ClinicalTrials.gov NCT05921591 · fetched Nov 12, 2026
- A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic EsophagitisPHASE2 · COMPLETED · started Oct 29, 2021ClinicalTrials.gov NCT05084963 · fetched Nov 12, 2026